BR112018071586A2 - uso de beta-agonistas da tireoide - Google Patents
uso de beta-agonistas da tireoideInfo
- Publication number
- BR112018071586A2 BR112018071586A2 BR112018071586-7A BR112018071586A BR112018071586A2 BR 112018071586 A2 BR112018071586 A2 BR 112018071586A2 BR 112018071586 A BR112018071586 A BR 112018071586A BR 112018071586 A2 BR112018071586 A2 BR 112018071586A2
- Authority
- BR
- Brazil
- Prior art keywords
- agonists
- thyroid beta
- thyroid
- beta
- adrenoleukodystrophy
- Prior art date
Links
- 229940125388 beta agonist Drugs 0.000 title 1
- 210000001685 thyroid gland Anatomy 0.000 title 1
- 201000011452 Adrenoleukodystrophy Diseases 0.000 abstract 1
- 102000009030 Member 1 Subfamily D ATP Binding Cassette Transporter Human genes 0.000 abstract 1
- 108010049137 Member 1 Subfamily D ATP Binding Cassette Transporter Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662326436P | 2016-04-22 | 2016-04-22 | |
| US62/326,436 | 2016-04-22 | ||
| PCT/US2017/029120 WO2017185087A1 (en) | 2016-04-22 | 2017-04-24 | Use of thyroid beta-agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112018071586A2 true BR112018071586A2 (pt) | 2019-02-12 |
Family
ID=60116400
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112018071586-7A BR112018071586A2 (pt) | 2016-04-22 | 2017-04-24 | uso de beta-agonistas da tireoide |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US11351183B2 (https=) |
| EP (1) | EP3445373B1 (https=) |
| JP (1) | JP6931042B2 (https=) |
| KR (1) | KR102407059B1 (https=) |
| AU (1) | AU2017252126B2 (https=) |
| BR (1) | BR112018071586A2 (https=) |
| CA (1) | CA3021681C (https=) |
| ES (1) | ES2992773T3 (https=) |
| MX (1) | MX385085B (https=) |
| WO (1) | WO2017185087A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3445373B1 (en) | 2016-04-22 | 2024-08-21 | Viking Therapeutics, Inc. | Use of thyroid beta-agonists |
| ES3053674T3 (en) | 2018-03-22 | 2026-01-23 | Viking Therapeutics Inc | Crystalline forms and methods of producing crystalline forms of a compound |
| WO2020117962A1 (en) | 2018-12-05 | 2020-06-11 | Viking Therapeutics, Inc. | Compositions for the treatment of fibrosis and inflammation |
| US11752161B2 (en) | 2020-03-27 | 2023-09-12 | Gannex Pharma Co., Ltd. | Pharmaceutical compositions, method of making and method of using thereof |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040091455A1 (en) | 2002-10-31 | 2004-05-13 | Zeldis Jerome B. | Methods of using and compositions comprising immunomodulatory compounds for treatment and management of macular degeneration |
| CA2543132A1 (en) | 2003-10-23 | 2005-05-19 | Celgene Corporation | Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain |
| CN1882327A (zh) | 2003-11-19 | 2006-12-20 | 症变治疗公司 | 含磷的新的拟甲状腺素药 |
| WO2006128058A2 (en) | 2005-05-26 | 2006-11-30 | Metabasis Therapeutics, Inc. | Thyromimetics for the treatment of fatty liver diseases |
| CA2638753A1 (en) | 2004-12-08 | 2006-06-15 | Sirion Therapeutics, Inc. | Methods, assays and compositions for treating retinol-related diseases |
| WO2006128056A2 (en) * | 2005-05-26 | 2006-11-30 | Metabasis Therapeutics, Inc. | Novel phosphinic acid-containing thyromimetics |
| EP1987827A1 (en) | 2006-02-20 | 2008-11-05 | Takeda Pharmaceutical Company Limited | Novel pharmaceutical |
| US20110071208A1 (en) | 2009-06-05 | 2011-03-24 | Protiva Biotherapeutics, Inc. | Lipid encapsulated dicer-substrate interfering rna |
| WO2011038207A1 (en) * | 2009-09-25 | 2011-03-31 | Metabasis Therapeutics, Inc. | Phosphorus-containing thyroid hormone receptor agonists and methods of use |
| CN103649103A (zh) | 2011-06-21 | 2014-03-19 | 阿尔尼拉姆医药品有限公司 | 用于抑制载脂蛋白c-iii(apoc3)基因表达的组合物与方法 |
| WO2014178892A1 (en) | 2013-05-03 | 2014-11-06 | Scanlan Thomas S | Use of sobetirome in the treatment of x-linked adrenolenoleukodystrophy |
| EP3259246B1 (en) | 2015-02-20 | 2023-03-22 | Oregon Health & Science University | Derivatives of sobetirome |
| EP3423379B1 (en) | 2016-02-29 | 2020-04-01 | Philip Morris Products S.a.s. | Hinge-lid container and blank |
| EP3445373B1 (en) | 2016-04-22 | 2024-08-21 | Viking Therapeutics, Inc. | Use of thyroid beta-agonists |
| CA3021677C (en) | 2016-04-22 | 2024-11-12 | Viking Therapeutics, Inc. | USE OF BETA-AGONISTS OF THYROID HORMONES |
| CN109475121B (zh) | 2016-05-18 | 2021-06-25 | 俄勒冈健康科学大学 | 苏比替罗衍生物 |
-
2017
- 2017-04-24 EP EP17786798.3A patent/EP3445373B1/en active Active
- 2017-04-24 MX MX2018012900A patent/MX385085B/es unknown
- 2017-04-24 WO PCT/US2017/029120 patent/WO2017185087A1/en not_active Ceased
- 2017-04-24 US US16/095,228 patent/US11351183B2/en active Active
- 2017-04-24 AU AU2017252126A patent/AU2017252126B2/en active Active
- 2017-04-24 ES ES17786798T patent/ES2992773T3/es active Active
- 2017-04-24 KR KR1020187033713A patent/KR102407059B1/ko active Active
- 2017-04-24 BR BR112018071586-7A patent/BR112018071586A2/pt not_active Application Discontinuation
- 2017-04-24 CA CA3021681A patent/CA3021681C/en active Active
- 2017-04-24 JP JP2019507069A patent/JP6931042B2/ja active Active
-
2022
- 2022-05-06 US US17/738,621 patent/US11951114B2/en active Active
-
2024
- 2024-03-05 US US18/595,919 patent/US12440502B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP6931042B2 (ja) | 2021-09-01 |
| MX2018012900A (es) | 2019-07-01 |
| WO2017185087A1 (en) | 2017-10-26 |
| KR20190039027A (ko) | 2019-04-10 |
| KR102407059B1 (ko) | 2022-06-10 |
| US20220257618A1 (en) | 2022-08-18 |
| CA3021681C (en) | 2024-09-24 |
| JP2019515033A (ja) | 2019-06-06 |
| EP3445373B1 (en) | 2024-08-21 |
| US20250000880A1 (en) | 2025-01-02 |
| US11951114B2 (en) | 2024-04-09 |
| CA3021681A1 (en) | 2017-10-26 |
| AU2017252126B2 (en) | 2023-02-09 |
| EP3445373A4 (en) | 2019-12-18 |
| AU2017252126A1 (en) | 2018-11-08 |
| ES2992773T3 (en) | 2024-12-18 |
| EP3445373A1 (en) | 2019-02-27 |
| US20190321379A1 (en) | 2019-10-24 |
| MX385085B (es) | 2025-03-14 |
| US11351183B2 (en) | 2022-06-07 |
| US12440502B2 (en) | 2025-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2022000448A1 (es) | Autoinyector (divisional solicitud no. 201903061) | |
| ZA202107931B (en) | Anti-tau antibodies and methods of use | |
| PH12020550781A1 (en) | Anti-jagged1 antibodies and methods of use | |
| MX374788B (es) | Anticuerpos anti-tim3 y metodos de uso. | |
| MX386587B (es) | ANTICUERPOS ANTI-CD79b Y MÉTODOS DE USO. | |
| CY1124521T1 (el) | Σκευασματα αντισωματος anti-cd19 | |
| EA201791029A1 (ru) | Антитела против интерлейкина-33 и их применение | |
| EA201790545A1 (ru) | Антитела и иммуноконъюгаты против her2 | |
| CL2019001381A1 (es) | Método para el tratamiento de glomeruloesclerosis segmentaria focal. | |
| CR20200089A (es) | Compuestos espirocíclicos y sus métodos de preparación y uso | |
| BR112017027721A2 (pt) | formulação de alta concentração | |
| MX2016016233A (es) | Anticuerpos anti-lgr5 y sus usos. | |
| MX2018005987A (es) | Compuestos heterociclicos para el tratamiento de enfermedades. | |
| BR112018071586A2 (pt) | uso de beta-agonistas da tireoide | |
| CO2017010621A2 (es) | Compuestos bicíclicos fusionados para el tratamiento de enfermedades | |
| BR112018071559A2 (pt) | uso de beta-agonistas da tireoide | |
| CR20180110A (es) | Libobactina para uso en el tratamiento de la mastitis bovina | |
| CL2018003283S1 (es) | Automóvil (divisional solicitud 201800156). | |
| UA114708U (uk) | Тяговий привід електробуса | |
| EA201890727A1 (ru) | Модуляторы взаимодействия сестрина-gator2 и их применение | |
| UA101750U (ru) | Применение омега как органопротектора при токсическом гепатите | |
| UA101964U (uk) | Застосування декаметоксину як протимікробного засобу проти бактерій виду pseudomonas aeruginosa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI N? 10196/2001, QUE MODIFICOU A LEI N? 9279/96, A CONCESS?O DA PATENTE EST? CONDICIONADA ? ANU?NCIA PR?VIA DA ANVISA. CONSIDERANDO A APROVA??O DOS TERMOS DO PARECER N? 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL N? 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVID?NCIAS CAB?VEIS. |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2631 DE 08/06/2021 POR TER SIDO INDEVIDA. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B12B | Appeal against refusal [chapter 12.2 patent gazette] |